Hansen PE

Title : Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics - Rasmussen_2015_Pharmacogenomics_16_649

Author(s) : Rasmussen HB , Bjerre D , Linnet K , Jurgens G , Dalhoff K , Stefansson H , Hankemeier T , Kaddurah-Daouk R , Taboureau O , Brunak S , Houmann T , Jeppesen P , Pagsberg AK , Plessen K , Dyrborg J , Hansen PR , Hansen PE , Hughes T , Werge T

Ref : Pharmacogenomics , 16 :649 , 2015

Abstract :

PubMedSearch : Rasmussen_2015_Pharmacogenomics_16_649

PubMedID: 25896426

Title : Chemical constituents from Sonneratia ovata Backer and their in vitro cytotoxicity and acetylcholinesterase inhibitory activities - Nguyen_2015_Bioorg.Med.Chem.Lett_25_2366

Author(s) : Nguyen TH , Pham HV , Pham NK , Quach ND , Pudhom K , Hansen PE , Nguyen KP

Ref : Bioorganic & Medicinal Chemistry Lett , 25 :2366 , 2015

Abstract :

PubMedSearch : Nguyen_2015_Bioorg.Med.Chem.Lett_25_2366

PubMedID: 25933595

Hansen PE

References (2)

1. Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics - Rasmussen_2015_Pharmacogenomics_16_649

2. Chemical constituents from Sonneratia ovata Backer and their in vitro cytotoxicity and acetylcholinesterase inhibitory activities - Nguyen_2015_Bioorg.Med.Chem.Lett_25_2366